Missing/wrong data?
Log in to edit
Adjuvant Sorafenib for Renal Cell Carcinoma at Intermediate or High Risk of Relapse: Results From the SORCE Randomized Phase III Intergroup Trial
scientific article published on 14 October 2020
Author/s
author: Eleni Frangou, Richard S Kaplan, Ian D Davis, James Larkin, Steven Joniau, Gregers G Hermann, Joaquim Bellmunt, Grant D. Stewart, Mahesh K B Parmar, Axel Bex
Work details
Publication date
October 14, 2020
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.